Who
Regina Margaret Graul
Director and Officer
Company insider
Files Form 4 as: President, Cyclerion Therapeutics.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Jan 2024
- Last trade
- 14 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 18 Aug 2026 | Cyclerion TherapeuticsBiotechnology | SEC FORM 4 Code M | $184K55,849 at $3.30 | filing |
| 14 Aug 2026filed 18 Aug 2026 | Cyclerion TherapeuticsBiotechnology | SEC FORM 4 Code F | $184K48,629 at $3.79 | filing |
| 14 Aug 2026filed 18 Aug 2026 | Cyclerion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —55,849 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | Cyclerion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —55,849 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | Cyclerion TherapeuticsBiotechnology | SEC FORM 4 Code M | $184K55,849 at $3.30 | filing |
| 14 Aug 2026filed 18 Aug 2026 | Cyclerion TherapeuticsBiotechnology | SEC FORM 4 Code F | $184K48,629 at $3.79 | filing |
| 5 Aug 2024filed 7 Aug 2024 | Cyclerion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,849 at $0.00 | filing |
| 1 Jan 2024filed 26 Jan 2024 | Cyclerion TherapeuticsBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.